Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

ePharmaSolutions Partners with iTrials

By Pharmaceutical Processing | May 11, 2010

ePharmaSolutions, a provider of clinical research technologies and services, has entered into a relationship with iTrials to help improve the site selection and patient recruitment process.

“For the last 10 years iTrials has developed one of the industry’s largest HIPAA-compliant sets of longitudinal patient data, linking more than 80 million patients with over 350,000 physicians including each patient’s diagnoses, procedure events, age, gender and even original referral physician,” stated Lance Converse, CEO of ePharmaSolutions. “This data is very helpful in both protocol/site feasibility and patient recruitment campaigns and will be integrated into our Site Feasibility Application (www.epharmasolutions.com/sfa) for better site profiling and selection,” Converse continued.

ePharmaSolutions plans to integrate iTrials’ longitudinal patient database into its CRID (Clinical Research Investigator Database), linking practicing physicians and experienced research Investigators with iTrials’ patient data to provide detailed views on each Investigator’s protocol-specific patient populations from within their own practice and their established referral networks. Those patient profiles can be tagged for recruitment by the physicians after they are selected for the study.

Pharmaceutical companies will be able to contract directly with ePharmaSolutions to provide this service at the study level and/or license the SFA (Site Feasibility Application) for self-service access to the global Investigator database, now including iTrials’ patient profiling tools with validated online feasibility survey tools and campaign management and reporting solutions.

“Our new partnership will provide the pharmaceutical industry with actionable data to help improve site feasibility and patient recruitment that until now has been either too expensive or not packaged in a way that was meaningful to study teams,” stated Mike Hassell, CEO of iTrials. “We are now in a position to support our clients’ needs at both the study and enterprise level,” added Hassell.

 

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE